Similar articles

• How poor countries can gain access to cheap drugs.

  Fleck F. Fleck F. BMJ. 2003 Sep 20;327(7416):642. doi: 10.1136/bmj.327.7416.642-b. BMJ. 2003. PMID: 14500433 Free PMC article. No abstract available.
• [How are prices for important drugs stipulated in poor countries?].

  Lien L. Lien L. Tidsskr Nor Laegeforen. 2003 Apr 3;123(7):958-9. Tidsskr Nor Laegeforen. 2003. PMID: 12737074 Norwegian. No abstract available.
• New deal from the World Trade Organisation.

  Pollock AM, Price D. Pollock AM, et al. BMJ. 2003 Sep 13;327(7415):571-2. doi: 10.1136/bmj.327.7415.571. BMJ. 2003. PMID: 12969897 Free PMC article. No abstract available.
• The concept of essential medicines: lessons for rich countries.

  Hogerzeil HV. Hogerzeil HV. BMJ. 2004 Nov 13;329(7475):1169-72. doi: 10.1136/bmj.329.7475.1169. BMJ. 2004. PMID: 15539676 Free PMC article. Review.
• Spurious and counterfeit drugs: a growing industry in the developing world.

  Gautam CS, Utreja A, Singal GL. Gautam CS, et al. Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213. Postgrad Med J. 2009. PMID: 19520877 Review.